171 related articles for article (PubMed ID: 7850822)
1. Thrombolytic therapy of acute myocardial infarction alters collagen metabolism.
Høst NB; Hansen SS; Jensen LT; Husum D; Nielsen JD
Cardiology; 1994; 85(5):323-33. PubMed ID: 7850822
[TBL] [Abstract][Full Text] [Related]
2. Effect on collagen metabolism of thrombolytic therapy with tissue-plasminogen activator. A randomized, placebo-controlled study.
Høst NB; Stoltenberg MB; Jensen LT; Larsen OG; Aurup P
Eur J Clin Invest; 1995 Jan; 25(1):15-8. PubMed ID: 7705381
[TBL] [Abstract][Full Text] [Related]
3. Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.
Peuhkurinen K; Risteli L; Jounela A; Risteli J
Am Heart J; 1996 Jan; 131(1):7-13. PubMed ID: 8554022
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic therapy with streptokinase stimulates collagen breakdown.
Peuhkurinen KJ; Risteli L; Melkko JT; Linnaluoto M; Jounela A; Risteli J
Circulation; 1991 Jun; 83(6):1969-75. PubMed ID: 2040049
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
6. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
7. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Van de Werf F
J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802
[TBL] [Abstract][Full Text] [Related]
8. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
9. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
10. Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction.
Radovan J; Vaclav P; Petr W; Jan C; Michal A; Richard P; Martina P
Mol Cell Biochem; 2006 Dec; 293(1-2):71-8. PubMed ID: 16933032
[TBL] [Abstract][Full Text] [Related]
11. "Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.
White HD; Cross DB; Williams BF; Norris RM; Woo KS; Hamer AW; Elliott JM; Ormiston JA
Am J Cardiol; 1995 Jan; 75(2):172-4. PubMed ID: 7810496
[No Abstract] [Full Text] [Related]
12. Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Van de Werf F
J Am Coll Cardiol; 1992 Jul; 20(1):36-41. PubMed ID: 1607536
[TBL] [Abstract][Full Text] [Related]
13. Thrombolysis in acute myocardial infarction.
Holmberg SR
Br J Hosp Med; 1992 Apr 15-May 5; 47(8):572-6, 578-80. PubMed ID: 1591557
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
[TBL] [Abstract][Full Text] [Related]
15. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
GUSTO Angiographic Investigators
N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.
Naylor CD; Armstrong PW
CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946
[TBL] [Abstract][Full Text] [Related]
17. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
18. The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction.
Høst NB; Jensen LT; Bendixen PM; Jensen SE; Koldkjaer OG; Simonsen EE
Am J Cardiol; 1995 Nov; 76(12):869-73. PubMed ID: 7484822
[TBL] [Abstract][Full Text] [Related]
19. Effect of coronary revascularization on serum collagen biomarkers and left ventricular remodeling in patients with acute myocardial infarction.
Ren HZ; Zhang XS; Wang LX
Heart Lung; 2012; 41(4):344-9. PubMed ID: 22054723
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of serum collagen biomakers on the outcome of acute myocardial infarction treated with percutaneous coronary intervention.
Gao H; Zhang XS; Zhao Q; Ma LL; Wang LX
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):272-6. PubMed ID: 24441293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
